Uncoupling proteins in heart failure

Current Heart Failure Reports

Volumn 5, Issue 2, 2008, Pages 75-79

  Laskowski, Karl R ^a   Russell III, Raymond R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; REACTIVE OXYGEN METABOLITE; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2; MITOCHONDRIAL UNCOUPLING PROTEIN 3; UNCLASSIFIED DRUG;

DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; HEART FAILURE; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; ANIMAL; DISEASE COURSE; DISEASE MODEL; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; MALE; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SENSITIVITY AND SPECIFICITY;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOWN-REGULATION; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; ION CHANNELS; MALE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 58149115367     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-008-0013-1     Document Type: Review

References (49)

1. Benjamin IJ, SchnCider MD: Learning from failure: congestive heart failure in the postgenomic age. J Clin Invest 2005, 115:495-499.
2. deGoma EM, Vagelos RH, Fowler MB, Ashley EA: Emerging therapies for the management of decompensated heart failure: From bench to bedside. J Am Coll Cardiol 2006, 48:2397-2409.
3. Hwang JJ, Allen PD, Tseng GC, et al.: Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 2002, 10:31-44.
4. Chen Y, Park S, Li Y, et al.: Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 2003, 14:251-260.
5. Depré C, Shipley GL, Chen W, et al.: Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 1998, 4:1269-1275.
6. Young ME, Patil S, Ying J, et al.: Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. FASEB J 2001, 15:833-845.
7. Razeghi P, Young ME, Ying J, et al.: Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 2002, 97:203-209.
8. Taegtmeyer H, Razeghi P, Young ME: Mitochondrial proteins in hypertrophy and atrophy: A transcript analysis in rat heart. Clin Exp Pharmacol Physiol 2002, 29:346-350.
9. Giordano FJ: Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:500-508.
10. Givertz MM, Colucci WS: New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet 1998, 352(Suppl 1):SI34-SI38.
11. Diaz-Velez CR, Garcia-Castineiras S, Mendoza-Ramos E, Hernandez-Lopez E: Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 1996, 131:146-152.
12. Mallat Z, Philip I, Lebret M, et al.: Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998, 97:1536-1539.
13. Baumer AT, Flesch M, Wang X, et al.: Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 2000, 32:121-130.
14. Sam F, Kerstetter DL, Pimental DR, et al.: Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 2005, 11:473-480.
15. Nojiri H, Shimizu T, Funakoshi M, et al.: Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem 2006, 281:33789-33801.
16. Hiroi S, Harada H, Nishi H, et al.: Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 1999, 261:332-339.
17. Valenti L, Conte D, Piperno A, et al.: The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J Med Genet 2004, 41:946-950.
18. Nakamura K, Kusano, KF, Matsubara H, et al.: Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy. J Card Fail 2005, 11:117-123.
19. Ye G, Metreveli NS, Ren J, Epstein, PN: Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 2003, 52:777-783.
20. Kawai K, Qin F, Shite J, et al.: Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy. Am J Physiol Heart Circ Physiol 2004, 287:H1003-H1012.
21. Shiomi T, Tsutsui H, Matsusaka H, et al.: Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2004, 109:544-549.
22. Fleury C, NeveroAa M, Collins S, et al.: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997, 15:269-272.
23. Gimeno RE, Dembski M, Weng X, et al.: Cloning and characterization of an uncoupling protein homolog: A potential molecular mediator of human thermogenesis. Diabetes 1997, 46:900-906.
24. Sack MN: Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc Res 2006, 72:210-219.
25. Murray AJ, Anderson RE, Watson GC, et al.: Uncoupling proteins in human heart. Lancet 2004, 364:1786-1788.
26. Aidal-Puig A, Solanes G, Grujic D, et al.: UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 1997, 235:79-82.
27. Matsuda J, Hosoda K, Itoh H, et al.: Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: Their gene expression in rats fed high-fat diet. FEBS Lett 1997, 418:200-204.
28. Douette P, Sluse FE: MitochonNrial uncoupling proteins: new insights from functional and proteomic studies. Free Radic Biol Med 2006, 40:1097-1107.
29. Liu SS: Generating, partitioning, targeting and functioning of superoxide in mitochondria. Biosci Rep 1997, 17:259-272.
30. Vidal-Puig AJ, Grujic D, Zhang CY, et al.: Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 2000, 275:16258-16266.
31. Mattiasson G, Shamloo M, Gido G, et al.: Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med 2003, 9:1062-1068.
32. Bechmann I, Diano S, Warden CH, et al.: Brain mitochondrial uncoupling protein 2 (UCP2): A protective stress signal in neuronal injury. Biochem Pharmacol 2002, 64:363-367.
33. Teshima Y, Akao M, Jones SP, Marban E: Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 2003, 93:192-200.
34. Fox KF, Cowie MR, Wood DA, et al.: Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J 2001, 22:228-236.
35. Bienengraeber M, Ozcan C, Terzic A: Stable transfection of UCP1 confers resistance to hypoxia/reoxygenation in a heart-derived cell line. J Mol Cell Cardiol 2003, 35:861-865.
36. Hoerter J, Gonzalez-Barroso MD, Couplan E, et al.: Mitochondrial uncoupling protein 1 expressed in the heart of transgenic mice protects against ischemic-reperfusion damage. Circulation 2004, 110:528-533.
37. Bodyak N, Rigor DL, Chen YS, et al.: Uncoupling protein-2 modulates cell viability in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol 2007, 293:H829-H835.
38. McLeod CJ, Aziz A, Hoyt RF Jr, et al.: Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia. J Biol Chem 2005, 280:33470-33476.
39. Guo P, Mizushige K, Noma T, et al.: Association of uncoupling protein-2 expression with increased reactive oxygen species in residual myocardium of the enlarged left ventricle after myocardial infarction. Heart Vessels 2005, 20:61-65.
40. Boss O, Samec S, Dulloo A, et al.: Tissue-dependent upregulation of rat uncoupling protein-2 expression in response to fasting or cold. FEBS Lett 1997, 412:111-114.
41. Blanc J, Alves-Guerra MC, Esposito B, et al.: Protective role of uncoupling protein 2 in atherosclerosis. Circulation 2003, 107:388-390.
42. Oberkofler H, Iglseder B, Klein K, et al.: Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2005, 25:604-610.
43. Noma T, Nishiyama A, Mizushige K, et al.: Possible role of uncoupling protein in regulation of myocardial energy metabolism in aortic regurgitation model rats. FASEB J 2001, 15:1206-1208.
44. Neubauer S: The failing heart - an engine out of fuel. N Engl J Med 2007, 356: 1140-1151.
45. Ashrafian H, Frenneaux MP, Opie LH, et al.: Metabolic mechanisms in heart failure. Circulation 2007, 116:434-448.
46. Hesselink MK, Schrauwen P: Uncoupling proteins in the failing human heart: Friend or foe? Lancet 2005, 365:385-386.
47. Zhou M, Lin BZ, Coughlin S, et al.: UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase. Am J Physiol 2000, 279:E622-E629.
48. Stoppani J, Hildebrandt AL, Sakamoto K, et al.: AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle. Am J Physiol 2002, 283:E1239-E1248.
49. Russell RR III, Li J, Coven DL, et al.: AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 2004, 114:495-503.